IDiyas

For the Inventor, By the Inventor

Salt Lake City, UT, United States of America

Sean V Tavtigian

USPTO Granted Patents = 26 

 

Average Co-Inventor Count = 4.3

ph-index = 13

Forward Citations = 370(Granted Patents)


Location History:

  • Lyons, FR (2010)
  • Salt Lake City, UT (US) (1998 - 2014)

Company Filing History:

goldMedal16 out of 116 
 
Myriad Genetics, Inc.
 patents
silverMedal5 out of 1,644 
 
University of Utah Research Foundation
 patents
bronzeMedal3 out of 5,444 
 
University of Texas System
 patents
4. 3 out of 80 
 
Endorecherche, Inc.
 patents
5. 3 out of 2,595 
 
University of Pennsylvania
 patents
6. 2 out of 2 
 
Myraid Genetics, Inc.
 patents
7. 2 out of 28 
 
The United States of America As Represented by the Secretary of Health
 patents
8. 2 out of 1,215 
 
The United States of America As Represented by the Department of Health
 patents
9. 1 out of 36 
 
Hsc Research and Development Limited Partnership
 patents
10. 1 out of 1 
 
Hsc Research & Development Limited Parntership
 patent
11. 1 out of 1 
 
Myriad Genectics, Inc.
 patent
12. 1 out of 1 
 
Hsc Reseach & Development Limited Partnership
 patent
13. 1 out of 165 
 
The Hospital for Sick Children
 patents
14. 5 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2014

Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents
1. 8735066 - Tumor suppressor designated TS10Q23.3 (2014-05-27),
2. 7732576 - Tumor suppressor designated TS10Q23.3 (2010-06-08),
3. 7217795 - Tumor suppressor designated TS10q23.3 (2007-05-15),
4. 7129040 - Tumor suppressor designated TS10q23.3 (2006-10-31),
5. 6844189 - Chromosome 17P-linked prostate cancer susceptibility gene (2005-01-18),
6. 6482795 - Tumor suppressor designated TS10q23.3 (2002-11-19),
7. 6465629 - BRG1 is a tumor suppressor that is mutated in prostate and other cancer types (2002-10-15),
8. 6444419 - TMPRSS2 is a tumor suppressor (2002-09-03),
9. 6440699 - Prostate cancer susceptible CA7 CG04 gene (2002-08-27),
10. 6337192 - MMSC1-an MMAC1 interacting protein (2002-01-08),
11. 6333403 - Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes (2001-12-25),
12. 6331614 - Human CDC14A gene (2001-12-18),
13. 6291173 - MMSC2—an MMAC1 interacting protein (2001-09-18),
14. 6262242 - Tumor suppressor designated TS10Q23.3 (2001-07-17),
15. 6235263 - Carboxy-terminal BRCA1 interacting protein (2001-05-22),

Title: The Innovative Journey of Sean V Tavtigian

Introduction:

Sean V Tavtigian is a renowned inventor based in Salt Lake City, UT (US) known for his groundbreaking contributions to the field of technology and science.

Latest Patents:

Sean V Tavtigian holds several patents in the areas of biotechnology, genetics, and medical devices, showcasing his commitment to pushing the boundaries of innovation.

Career Highlights:

With a career spanning over two decades, Sean V Tavtigian has worked tirelessly to develop cutting-edge solutions that have revolutionized the industry. His keen eye for detail and passion for discovery have led to numerous breakthroughs.

Collaborations:

Throughout his career, Sean V Tavtigian has collaborated with leading researchers, scientists, and institutions to further his research and bring his inventions to life. His collaborative spirit has been instrumental in his success.

Conclusion:

In conclusion, Sean V Tavtigian's dedication to innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire and shape the future of technology and science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…